Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Chemical/toxin
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
RatChemical/toxinWistarFemalen = 6 animals per groupOral (intraduodenal for the pylorus ligature model)1 to 10 mg/kg orally in vivo; 1 to 1000 micrograms/ml in vi…Treatment started after ulcer induction (healing rather than preventive protoco…
Model: Chronic gastric ulcer induced in rats by serosal application of 80% acetic acid; pylorus ligature model used for antisecretory assessment; gastrointestinal motility assessed in mice
Oral HEMR at 10 mg/kg reduced gastric ulcer area by 53% relative to the vehicle group (120.0 plus or minus 8.3 square millimetres), increased gastric mucin, and reduced oxidative and inflammatory markers at the ulcer site. It did not alter gastric secretion, gastrointestinal motility or Helicobacte…
Extraction: extract · Supplied extraction confidence: 0.75. Machine-extracted fields require source verification.